09/17/2013
https://www.congress.gov...
"these agreements that have been negotiated under this administration have done more to open the door toward these types of activities than I ever would have anticipated"
"We talked about the certainty that the industry needs to start populating the field with more biosimilars."
"I know this is an issue that doesn't necessarily fit natural to Congress to be funding physician and provider education, but we're talking about next year reports suggesting that 8 of the top 10 drugs..."
"If we get a whole rash of State laws that erect barriers it doesn't really matter what education you do if the law prevents the usage of these biosimilars."